Cryptococcus Gattii in the United States: Genotypic Diversity of Human and Veterinary Isolates

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2013 Sep 11

PMID 24019979

Citations 46

Authors

Shawn R Lockhart

Naureen Iqbal

Julie R Harris

Nina T Grossman

Emilio DeBess

Ron Wohrle

Nicola Marsden-Haug

Duc J Vugia

Affiliations

Soon will be listed here.

Abstract

Background: Cryptococcusgattii infections are being reported in the United States (US) with increasing frequency. Initially, US reports were primarily associated with an ongoing C. gattii outbreak in the Pacific Northwest (PNW) states of Washington and Oregon, starting in 2004. However, reports of C. gattii infections in patients from other US states have been increasing since 2009. Whether this is due to increasing frequency of disease, greater recognition within the clinical community, or both is currently unknown.

Methodology/principal Findings: During 2005-2013, a total of 273 C. gattii isolates from human and veterinary sources in 16 US states were collected. Of these, 214 (78%) were from the Pacific Northwest (PNW) and comprised primarily the clonal C. gattii genotypes VGIIa (64%), VGIIc (21%) and VGIIb (9%). The 59 isolates from outside the PNW were predominantly molecular types VGIII (44%) and VGI (41%). Genotyping using multilocus sequence typing revealed small clusters, including a cluster of VGI isolates from the southeastern US, and an unrelated cluster of VGI isolates and a large cluster of VGIII isolates from California. Most of the isolates were mating type MATα, including all of the VGII isolates, but one VGI and three VGIII isolates were mating type MATa.

Conclusions/significance: We provide the most comprehensive report to date of genotypic diversity of US C. gattii isolates both inside and outside of the PNW. C. gattii may have multiple endemic regions in the US, including a previously-unrecognized endemic region in the southeast. Regional clusters exist both in California and the Southeastern US. VGII strains associated with the PNW outbreak do not appear to have spread substantially beyond the PNW.

Citing Articles

Molecular epidemiological investigation of spp. carried by captive koalas () in Japan.

Omura M, Satoh K, Tamura T, Komori A, Makimura K Microbiol Spectr. 2024; 12(4):e0290323.

PMID: 38411053 PMC: 11210188. DOI: 10.1128/spectrum.02903-23.

Cryptococcal Meningoencephalitis in Phenotypically Normal Patients.

Cumagun P, Moore M, McCarty T, McGwin G, Pappas P Pathogens. 2023; 12(11).

PMID: 38003768 PMC: 10674724. DOI: 10.3390/pathogens12111303.

Global Analyses of Multi-Locus Sequence Typing Data Reveal Geographic Differentiation, Hybridization, and Recombination in the Species Complex.

Hitchcock M, Xu J J Fungi (Basel). 2023; 9(2).

PMID: 36836390 PMC: 9967412. DOI: 10.3390/jof9020276.

Genotypic Diversity and Antifungal Susceptibility of Clinical Isolates of Cryptococcus Gattii Species Complex from Argentina.

Taverna C, Arias B, Firacative C, Vivot M, Szusz W, Vivot W Mycopathologia. 2023; 188(1-2):51-61.

PMID: 36609823 DOI: 10.1007/s11046-022-00705-x.

A Fatal Fungal Infection: (VGI) Meningitis in Texas.

Nielsen M, Peterson J, Shine B, Hornak J, Esechie A, Bhatt S Open Forum Infect Dis. 2022; 9(7):ofac236.

PMID: 35854998 PMC: 9277648. DOI: 10.1093/ofid/ofac236.

References

Walraven C, Gerstein W, Hardison S, Wormley F, Lockhart S, Harris J . Fatal disseminated Cryptococcus gattii infection in New Mexico. PLoS One. 2011; 6(12):e28625. PMC: 3237461. DOI: 10.1371/journal.pone.0028625. View

Fraser J, Giles S, Wenink E, Geunes-Boyer S, Wright J, Diezmann S . Same-sex mating and the origin of the Vancouver Island Cryptococcus gattii outbreak. Nature. 2005; 437(7063):1360-4. DOI: 10.1038/nature04220. View

Stephen C, Lester S, Black W, Fyfe M, Raverty S . Multispecies outbreak of cryptococcosis on southern Vancouver Island, British Columbia. Can Vet J. 2002; 43(10):792-4. PMC: 339618. View

Friedman G, Fessel W, Udaltsova N, Hurley L . Cryptococcosis: the 1981-2000 epidemic. Mycoses. 2005; 48(2):122-5. DOI: 10.1111/j.1439-0507.2004.01082.x. View

Espinel-Ingroff A, Aller A, Canton E, Castanon-Olivares L, Chowdhary A, Cordoba S . Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole. Antimicrob Agents Chemother. 2012; 56(11):5898-906. PMC: 3486550. DOI: 10.1128/AAC.01115-12. View

Tamura K, Dudley J, Nei M, Kumar S . MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol. 2007; 24(8):1596-9. DOI: 10.1093/molbev/msm092. View

Galanis E, Hoang L, Kibsey P, Morshed M, Phillips P . Clinical presentation, diagnosis and management of Cryptococcus gattii cases: Lessons learned from British Columbia. Can J Infect Dis Med Microbiol. 2010; 20(1):23-8. PMC: 2690522. DOI: 10.1155/2009/719659. View

Bottone E, Kirschner P, Salkin I . Isolation of highly encapsulated Cryptococcus neoformans serotype B from a patient in New York City. J Clin Microbiol. 1986; 23(1):186-8. PMC: 268599. DOI: 10.1128/jcm.23.1.186-188.1986. View

Speed B, Dunt D . Clinical and host differences between infections with the two varieties of Cryptococcus neoformans. Clin Infect Dis. 1995; 21(1):28-34; discussion 35-6. DOI: 10.1093/clinids/21.1.28. View

10.

Bennett J, Kwon-Chung K, Howard D . Epidemiologic differences among serotypes of Cryptococcus neoformans. Am J Epidemiol. 1977; 105(6):582-6. DOI: 10.1093/oxfordjournals.aje.a112423. View

11.

Meyer W, Aanensen D, Boekhout T, Cogliati M, Diaz M, Esposto M . Consensus multi-locus sequence typing scheme for Cryptococcus neoformans and Cryptococcus gattii. Med Mycol. 2009; 47(6):561-70. PMC: 2884100. DOI: 10.1080/13693780902953886. View

12.

Hoang L, Maguire J, Doyle P, Fyfe M, Roscoe D . Cryptococcus neoformans infections at Vancouver Hospital and Health Sciences Centre (1997-2002): epidemiology, microbiology and histopathology. J Med Microbiol. 2004; 53(Pt 9):935-940. DOI: 10.1099/jmm.0.05427-0. View

13.

Chen Y, Chang S, Shih C, Hung C, Luhbd K, Pan Y . Clinical features and in vitro susceptibilities of two varieties of Cryptococcus neoformans in Taiwan. Diagn Microbiol Infect Dis. 2000; 36(3):175-83. DOI: 10.1016/s0732-8893(99)00137-6. View

14.

Pfeiffer T, Ellis D . Environmental isolation of Cryptococcus neoformans gattii from California. J Infect Dis. 1991; 163(4):929-30. DOI: 10.1093/infdis/163.4.929. View

15.

Diaz M, Boekhout T, Theelen B, Fell J . Molecular sequence analyses of the intergenic spacer (IGS) associated with rDNA of the two varieties of the pathogenic yeast, Cryptococcus neoformans. Syst Appl Microbiol. 2001; 23(4):535-45. DOI: 10.1016/S0723-2020(00)80028-4. View

16.

Mitchell D, Sorrell T, Allworth A, Heath C, McGregor A, Papanaoum K . Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome. Clin Infect Dis. 1995; 20(3):611-6. DOI: 10.1093/clinids/20.3.611. View

17.

Upton A, Fraser J, Kidd S, Bretz C, Bartlett K, Heitman J . First contemporary case of human infection with Cryptococcus gattii in Puget Sound: evidence for spread of the Vancouver Island outbreak. J Clin Microbiol. 2007; 45(9):3086-8. PMC: 2045307. DOI: 10.1128/JCM.00593-07. View

18.

Okamoto K, Hatakeyama S, Itoyama S, Nukui Y, Yoshino Y, Kitazawa T . Cryptococcus gattii genotype VGIIa infection in man, Japan, 2007. Emerg Infect Dis. 2010; 16(7):1155-7. PMC: 3321916. DOI: 10.3201/eid1607.100106. View

19.

Evans E . An immunologic comparison of 12 strains of Cryptococcus neoformans (Torula histolytica). Proc Soc Exp Biol Med. 1949; 71(4):644-6. DOI: 10.3181/00379727-71-17283. View

20.

Litvintseva A, Thakur R, Reller L, Mitchell T . Prevalence of clinical isolates of Cryptococcus gattii serotype C among patients with AIDS in Sub-Saharan Africa. J Infect Dis. 2005; 192(5):888-92. DOI: 10.1086/432486. View